Table 1.
Country | Years, Sex | Protopathic | Infliximab Use | Concomitant Treatment | Infection Site | Prognosis | Treatment |
---|---|---|---|---|---|---|---|
USA2 | 61, male | CD | 2.5 years | Prednisone, Budesonide, Azathioprine | Lung | Improve | Amphotericin B + Flucytosine, sequential Fluconazole |
Japan3 | 39, male | CD | 5 mg/kg for 8 months | None | Lung | Improve | Surgery |
Qatar4 | 54, male | CD | 5 mg/kg for 15 months | Prednisolone, Methotrexate |
Lung | Improve | Fluconazole |
USA5 | 53, male | CD | 3 years | Prednisolone, Azathioprine |
Lung | Improve | Fluconazole |
Japan6 | 35, male | CD | 8 doses | Prednisolone | Lung | Improve | Fluconazole |
China (Present case) | 51, male | UC | 400mg for 4 times | Glucocorticoid | Lung | Improve | Voriconazole |